News

Millions Affected by ADHD and Depression – Hungary at the Forefront of Solutions
Millions Affected by ADHD and Depression – Hungary at the Forefront of Solutions
2026.03.16.

According to estimates by the World Health Organization (WHO), around 1.3 billion people worldwide (approximately 16 percent of the global population) live with some form of disability. Projections suggest that by 2040 4.5 percent of the population will be affected by attention deficit hyperactivity disorder (ADHD), while 3.8 percent will suffer from major depression. These figures clearly indicate that in the coming decades neurological and psychiatric disorders, rehabilitation, and technologies aimed at restoring human abilities will become one of the most important areas of global innovation. Industry analyses estimate that the global bionics market will reach USD 8.2 billion by 2025 and could expand to as much as USD 17.5 billion by 2033.

More
Graduation Ceremony at Pázmány ITK
Graduation Ceremony at Pázmány ITK
2026.03.03.

On 19 February 2026, students and lecturers, family and friends gathered for the faculty's graduation ceremony. A large number of students received their diplomas at the event, including both Hungarian and foreign students, which reflects the growing international appeal of Pázmány ITK.

More
Spring-semester kick-off mentor training day at ITK
Spring-semester kick-off mentor training day at ITK
2026.02.25.

On the afternoon of February 13, we held a training session for members of the International Mentor Community. The goal of this session was to prepare the team professionally and strengthen our community as we began the spring semester.

More
Spring-semester kick-off mentor training day at ITK
Spring-semester kick-off mentor training day at ITK
2026.02.25.

On the afternoon of February 13, we held a training session for members of the International Mentor Community. The goal of this session was to prepare the team professionally and strengthen our community as we began the spring semester.

More
szechenyi-img-alt